Drug General Information |
Drug ID |
D00YEV
|
Former ID |
DNC007144
|
Drug Name |
BAICALEIN
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C15H10O5
|
InChI |
InChI=1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7,17-19H
|
InChIKey |
FXNFHKRTJBSTCS-UHFFFAOYSA-N
|
PubChem Compound ID |
|
PubChem Substance ID |
12209, 509734, 596570, 5403906, 8142409, 8147158, 8616665, 10319020, 11113153, 11114203, 11342029, 11362212, 11363321, 11365883, 11368445, 11372534, 11374312, 11376607, 11484308, 11487614, 11488282, 11491423, 11492352, 11494241, 11537766, 14824071, 22395190, 24870246, 26612582, 26679906, 26747176, 26747177, 26758283, 29203872, 39290387, 46499858, 47515418, 47810866, 48035247, 48110555, 48421895, 48428137, 49889783, 50104952, 50122813, 50786403, 53787168, 53800848, 57358247, 71822546
|
Target and Pathway |
Target(s) |
Lactoylglutathione lyase |
Target Info |
Inhibitor |
[2]
|
Tumor necrosis factor |
Target Info |
Inhibitor |
[3]
|
Xanthine dehydrogenase/oxidase |
Target Info |
Inhibitor |
[4]
|
L-selectin |
Target Info |
Inhibitor |
[5]
|
Prolyl endopeptidase |
Target Info |
Inhibitor |
[6]
|
P-selectin |
Target Info |
Inhibitor |
[5]
|
Arachidonate 5-lipoxygenase |
Target Info |
Inhibitor |
[7]
|
BioCyc Pathway
|
Methylglyoxal degradation IPWY-6353:Purine nucleotides degradation
|
Urate biosynthesis/inosine 5'-phosphate degradation
|
Guanosine nucleotides degradation
|
Adenosine nucleotides degradation
|
Retinoate biosynthesis IIPWY66-393:Aspirin-triggered lipoxin biosynthesis
|
Resolvin D biosynthesis
|
Leukotriene biosynthesis
|
Lipoxin biosynthesis
|
Aspirin triggered resolvin D biosynthesis
|
Aspirin triggered resolvin E biosynthesis
|
KEGG Pathway
|
Pyruvate metabolismhsa04010:MAPK signaling pathway
|
Cytokine-cytokine receptor interaction
|
NF-kappa B signaling pathway
|
Sphingolipid signaling pathway
|
mTOR signaling pathway
|
Apoptosis
|
TGF-beta signaling pathway
|
Osteoclast differentiation
|
Antigen processing and presentation
|
Toll-like receptor signaling pathway
|
NOD-like receptor signaling pathway
|
RIG-I-like receptor signaling pathway
|
Hematopoietic cell lineage
|
Natural killer cell mediated cytotoxicity
|
T cell receptor signaling pathway
|
Fc epsilon RI signaling pathway
|
TNF signaling pathway
|
Adipocytokine signaling pathway
|
Type II diabetes mellitus
|
Non-alcoholic fatty liver disease (NAFLD)
|
Type I diabetes mellitus
|
Alzheimer's disease
|
Amyotrophic lateral sclerosis (ALS)
|
Pertussis
|
Legionellosis
|
Leishmaniasis
|
Chagas disease (American trypanosomiasis)
|
African trypanosomiasis
|
Malaria
|
Toxoplasmosis
|
Amoebiasis
|
Tuberculosis
|
Hepatitis C
|
Hepatitis B
|
Influenza A
|
HTLV-I infection
|
Herpes simplex infection
|
Proteoglycans in cancer
|
Asthma
|
Inflammatory bowel disease (IBD)
|
Systemic lupus erythematosus
|
Rheumatoid arthritis
|
Allograft rejection
|
Graft-versus-host disease
|
Hypertrophic cardiomyopathy (HCM)
|
Dilated cardiomyopathyhsa00230:Purine metabolism
|
Caffeine metabolism
|
Drug metabolism - other enzymes
|
Metabolic pathways
|
Peroxisomehsa04514:Cell adhesion molecules (CAMs)hsa04614:Renin-angiotensin systemhsa04514:Cell adhesion molecules (CAMs)
|
Staphylococcus aureus infectionhsa00590:Arachidonic acid metabolism
|
Serotonergic synapse
|
Ovarian steroidogenesis
|
NetPath Pathway
|
TCR Signaling PathwayNetPath_11:TCR Signaling Pathway
|
IL2 Signaling Pathway
|
IL3 Signaling Pathway
|
IL4 Signaling Pathway
|
Leptin Signaling Pathway
|
RANKL Signaling Pathway
|
IL1 Signaling PathwayNetPath_20:IL9 Signaling Pathway
|
Leptin Signaling PathwayNetPath_16:IL4 Signaling Pathway
|
PANTHER Pathway
|
Apoptosis signaling pathway
|
Wnt signaling pathwayP02723:Adenine and hypoxanthine salvage pathway
|
Purine metabolismP04395:Vasopressin synthesis
|
Pathway Interaction Database
|
IL27-mediated signaling events
|
Canonical NF-kappaB pathway
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
Angiopoietin receptor Tie2-mediated signaling
|
Signaling events mediated by HDAC Class I
|
TNF receptor signaling pathway
|
Ceramide signaling pathway
|
amb2 Integrin signaling
|
RXR and RAR heterodimerization with other nuclear receptor
|
IL23-mediated signaling events
|
HIV-1 Nef: Negative effector of Fas and TNF-alpha
|
Caspase Cascade in Apoptosis
|
Cellular roles of Anthrax toxin
|
Downstream signaling in naï
|
IL4-mediated signaling events
|
PathWhiz Pathway
|
Pyruvaldehyde Degradation
|
Pyruvate MetabolismPW000453:Fc Epsilon Receptor I Signaling in Mast CellsPW000015:Caffeine Metabolism
|
Purine MetabolismPW000044:Arachidonic Acid Metabolism
|
Reactome
|
Pyruvate metabolismR-HSA-381340:Transcriptional regulation of white adipocyte differentiation
|
TNFR1-induced proapoptotic signaling
|
Regulation of TNFR1 signaling
|
TNFR1-induced NFkappaB signaling pathway
|
TNFR1-mediated ceramide production
|
TNFR2 non-canonical NF-kB pathway
|
TNF signalingR-HSA-74259:Purine catabolismR-HSA-198933:Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
|
Cell surface interactions at the vascular wallR-HSA-114608:Platelet degranulation
|
Cell surface interactions at the vascular wall
|
WikiPathways
|
Toll-like receptor signaling pathway
|
Monoamine Transport
|
SIDS Susceptibility Pathways
|
TGF Beta Signaling Pathway
|
Cytokines and Inflammatory Response
|
MAPK Signaling Pathway
|
EV release from cardiac cells and their functional effects
|
FAS pathway and Stress induction of HSP regulation
|
Apoptosis-related network due to altered Notch3 in ovarian cancer
|
Cardiac Hypertrophic Response
|
Transcriptional Regulation of White Adipocyte Differentiation
|
Aryl Hydrocarbon Receptor
|
Apoptosis
|
Nanoparticle triggered regulated necrosis
|
Amyotrophic lateral sclerosis (ALS)
|
Adipogenesis
|
Allograft Rejection
|
TNF alpha Signaling Pathway
|
TWEAK Signaling Pathway
|
Extrinsic Pathway for Apoptosis
|
Folate Metabolism
|
MicroRNAs in cardiomyocyte hypertrophy
|
Vitamin B12 Metabolism
|
Selenium Micronutrient Network
|
Regulation of toll-like receptor signaling pathway
|
Matrix MetalloproteinasesWP408:Oxidative Stress
|
Effects of Nitric Oxide
|
Metabolism of nucleotides
|
Selenium Micronutrient NetworkWP2806:Human Complement System
|
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
|
Cell surface interactions at the vascular wallWP2806:Human Complement System
|
Spinal Cord Injury
|
Cell surface interactions at the vascular wallWP2877:Vitamin D Receptor Pathway
|
Arachidonic acid metabolism
|
Eicosanoid Synthesis
|
References |
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5144). |
---|
REF 2 | Bioorg Med Chem. 2008 Apr 1;16(7):3969-75. Epub 2008 Jan 24.Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects. |
---|
REF 3 | Bioorg Med Chem Lett. 2010 Nov 1;20(21):6195-8. Epub 2010 Sep 16.Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening. |
---|
REF 4 | Inhibition of cow's milk xanthine oxidase by flavonoids. J Nat Prod. 1988 Mar-Apr;51(2):345-8. |
---|
REF 5 | J Med Chem. 2007 Mar 22;50(6):1101-15. Epub 2007 Feb 16.Rational design of novel, potent small molecule pan-selectin antagonists. |
---|
REF 6 | Bioorg Med Chem. 2008 Aug 1;16(15):7516-24. Epub 2008 Apr 29.Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor. |
---|
REF 7 | J Med Chem. 1991 Mar;34(3):1028-36.Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity. |